Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences NanoPharmaceuticals

Chittaranjan Patra's Biography

Chittaranjan Patra, Scientist & Ramanujan Fellow (DST, New Delhi) , Indian Institute of Chemical Technology

Chittaranjan Patra received his B.Sc (1995) and M.Sc (1997) in Chemistry from the University of Burdwan, W.B. He was awarded the “Dr. Mrigendranath Ghosh Gold Medal” for obtaining first class and first rank in B.Sc Chemistry (Hons) Examination in 1995 from The University of Burdwan, India. He completed his Ph.D. in Chemistry in 2003 (as CSIR Fellow: April 1998- March 2003) from National Chemical Laboratory (NCL), Pune. Thereafter, he received his postdoctoral experience (March 2003-October 2004) as ‘Nanotechnologist’ from Bar-Ilan University, Ramat-Gan, Israel. After that he moved to Mayo Clinic, Department of Biochemistry and Molecular Biology in October 2004 as postdoc followed by Assistant Professor in the same Department. Here Dr. Patra explored the field of nanobiotechnology for cancer and angiogenesis. Dr. Patra moved to CSIR-IICT-Hyderabad after receiving prestigious Ramnujan Fellowship, from DST-New Delhi.
He has 73 peer-reviewed publications in high impact international journals, 4 book chapters and 3 patents. Dr. Patra serves as repeated invited reviewer of more than 20 International journals such as Advanced Drug Delivery Review, Biomaterials, ChemComm, Nanomedicine, Organic Letters etc. Dr. Patra is the member of ACS, AACR, AAAS, CRSI, ISCA, ISCB, CBS-India, ABAP and he has delivered more than 20-invited talk. He serves as Editorial Board Member of ‘Nanoscience and Nanotechnology’, ‘Gene Therapy and Molecular Biology (GTMB)’ and ‘Journal of Nanomedicine & Nanotechnology’. Apart from that, he has received ‘Ramanujan Fellowship’ from DST, ‘Young Investigator Award’, Michael A. O’Connor Travel Award’ from Mayo Clinic angiogenesis symposium, QRS Best Scientist Award from CSIR-IICT. The World Science Congress (WSC), Kolkata felicitated Dr. Patra as ‘FLAME OF SCIENCE’ for lifetime contribution and excellence for the Noble Cause of Science.

Research Interest:
My group at CSIR-Indian Institute of Chemical Technology (IICT) is currently persuing various nanomedicine research projects aimed at developing advanced nanomaterials and nanoparticles drug delivery systems (DDS) for treatment of cancer, cardiovascular /ischemic disease and wound healing. Notably, cardiovascular disease (CVD) and cancer are globally the two leading causes of morbidity and mortality. According to World Health Organization (WHO), CVDs are the number one cause of death globally accounting for 17.3 million or 30% of total global deaths in 2008. Similarly, cancer is also a major public health problem in India and other developed countries. Cancer accounted for 8.2 million deaths (around 20% of all deaths) in 2007, according to WHO. Conventional treatment strategies for cancer and CVDs have several limitations and hence more effective alternative therapeutic approach especially nanomedicine are urgently needed.

Chittaranjan  Patra Image

Advanced Nanomaterials for Future Therapeutics

Friday, 11 September 2015 at 11:00

Add to Calendar ▼2015-09-11 11:00:002015-09-11 12:00:00Europe/LondonAdvanced Nanomaterials for Future TherapeuticsNanoPharmaceuticals in

This presentation will highlight the advanced nanomaterials and nanoparticles based drug delivery systems (DDS) for treatment of cancer, cardiovascular /ischemic disease and wound healing. It will further highlight the design and development of nanoparticles like europium hydroxide nanorods (EHNs), zinc oxide nanoflowers (ZON), graphene oxides and gold nanoparticles that exhibit excellent pro-angiogenic activities.

Add to Calendar ▼2015-09-10 00:00:002015-09-11 00:00:00Europe/LondonNanoPharmaceuticalsNanoPharmaceuticals in